Call/WhatsApp: +1 914 416 5343

Detection of DNA hypomethylation by methylation inhibitor: azacitidine in acute myeloid leukaemia and triple negative breast cancer.

Assess AZA treatment on cell viability in leukaemia and breast cell line and evaluate the predictability of DNA hypomethylation on KG1-a leukemic cell line and Mda-Mb231 breast cell after AZA treatment using High-Resolution Melt technique (HRM)

Leave a Reply